Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $112.96 million as of July 16, 2026. Its market cap has increased by 9.56% in one year.

Market Cap

112.96M

Enterprise Value

99.45M

1-Year Change

9.56%

Ranking

#4232

ChartMarket Cap Chart

Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $112.96M, an increase of 35.77%. That is a compound annual growth rate of 1.11%.

Market Cap History

Date	Market Cap	% Change
Jul 16, 2026	113.00M	10.03%
Dec 31, 2025	102.70M	37.48%
Dec 31, 2024	74.70M	-38.06%
Dec 29, 2023	120.60M	-7.44%
Dec 30, 2022	130.30M	46.40%
Dec 31, 2021	89.00M	21.92%
Dec 31, 2020	73.00M	10.11%
Dec 31, 2019	66.30M	-10.04%
Dec 31, 2018	73.70M	106.44%
Dec 29, 2017	35.70M	-24.52%
Dec 30, 2016	47.30M	79.85%
Dec 31, 2015	26.30M	10.04%
Dec 31, 2014	23.90M	-39.34%
Dec 31, 2013	39.40M	18.32%
Dec 31, 2012	33.30M	73.44%
Dec 30, 2011	19.20M	-39.81%
Dec 31, 2010	31.90M	-65.14%
Dec 31, 2009	91.50M	61.95%
Dec 31, 2008	56.50M	-63.00%
Dec 31, 2007	152.70M	62.27%
Dec 29, 2006	94.10M	31.24%
Dec 30, 2005	71.70M	-0.42%
Dec 31, 2004	72.00M	94.07%
Dec 31, 2003	37.10M	183.21%
Dec 31, 2002	13.10M	-52.88%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
enGene Therapeutics	127.28M
ProMIS Neurosciences	125.59M
Spruce Biosciences	125.06M
Fortress Biotech	123.24M
Vivani Medical	121.59M
Cue Biopharma	119.67M
Seer, Inc.	118.76M
Aldeyra Therapeutics	115.82M

Market Cap Rankings